These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 17002262)
1. Drug evaluation: AMG-531 for the treatment of thrombocytopenias. Rice L Curr Opin Investig Drugs; 2006 Sep; 7(9):834-41. PubMed ID: 17002262 [TBL] [Abstract][Full Text] [Related]
3. The role of AMG-531 in the treatment of thrombocytopenia in idiopathic thrombocytopenic purpura and myelodysplastic syndromes. Tiu RV; Sekeres MA Expert Opin Biol Ther; 2008 Jul; 8(7):1021-30. PubMed ID: 18549331 [TBL] [Abstract][Full Text] [Related]
6. The promise of thrombopoietins in the treatment of ITP. Kuter DJ Clin Adv Hematol Oncol; 2005 Jun; 3(6):464-6. PubMed ID: 16167023 [No Abstract] [Full Text] [Related]
7. Increasing the platelet count in chronic ITP. Nurden AT; Nurden P Lancet; 2008 Feb; 371(9610):362-4. PubMed ID: 18242396 [No Abstract] [Full Text] [Related]
8. An open-label, unit dose-finding study of AMG 531, a novel thrombopoiesis-stimulating peptibody, in patients with immune thrombocytopenic purpura. Newland A; Caulier MT; Kappers-Klunne M; Schipperus MR; Lefrere F; Zwaginga JJ; Christal J; Chen CF; Nichol JL Br J Haematol; 2006 Nov; 135(4):547-53. PubMed ID: 17061981 [TBL] [Abstract][Full Text] [Related]
9. AMG 531 for chronic ITP. Tauro S N Engl J Med; 2007 Jan; 356(3):307; author reply 308. PubMed ID: 17229962 [No Abstract] [Full Text] [Related]
10. AMG 531 for chronic ITP. Prasad K N Engl J Med; 2007 Jan; 356(3):307-8; author reply 308. PubMed ID: 17240535 [No Abstract] [Full Text] [Related]
11. New drugs for familiar therapeutic targets: thrombopoietin receptor agonists and immune thrombocytopenic purpura. Kuter DJ Eur J Haematol Suppl; 2008 Feb; (69):9-18. PubMed ID: 18211568 [TBL] [Abstract][Full Text] [Related]